Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Good old sherm. Satisfied with the minuscule dividend increase when a much higher dividend, which is in the best interest of all CMCL shareholders, is easily affordable, & would offset the severe Zimbabwe economic & political risk that inhibits gold stock investors from buying CMCL? Happy that 2020 production is stagnant?
Zimbabwe repealed it's onerous digitization law that required CMCL to divest 51% ownership of Blanket. Since the law has been repealed, why doesn't CMCL have returned to it ALL 51% of the ownership it was forced to divest under a repealed law?
Looks like another triple top has formed. The minuscule increase in the dividend was a slap in the face to all CMCL shareholders by CMCL management A much higher dividend, certainly affordable at $1450 to $1550 gold, is needed to increase the share price & overcome the Zimbabwe economic & political risk that inhibits many gold stock investors from buying CMCL. In addition, the gold production for 2020 was very disappointing.
Zimdollar drops 135,7% – NewsDay Zimbabwe October 4, 2019
BY MISHMA CHAKANYUKA
"THE Zimdollar has devalued by 135,7% to $15,25 against the greenback on the interbank market since it was declared the sole legal tender on June 24, owing to persistent foreign currency shortages and the deteriorating economic environment.
When the Reserve Bank of Zimbabwe scrapped the use of a basket of other foreign currencies, the Zimdollar was trading at US$1:2,5, but as of yesterday, the interbank rate stood at US$1:$15,25.
The interbank foreign exchange market was introduced in February this year to allow companies to trade forex, but access to foreign currency has remained challenging for businesses.
On the parallel market, the local currency was trading at 1:$17 against the greenback, a testimony of serious hard currency scarcities battering the economy.
This comes after the International Monetary Fund team which was in the country for the Article IV Consultation that coincided with the first review of the Staff-Monitored Programme last month told authorities that there was need to contain fiscal spending consistent with non-inflationary financing, tighten monetary policy to stabilise the exchange rate and start rebuilding confidence in the national currency.
The Washington-based Bretton Wood institution noted that weakening confidence, policy uncertainty, a continuation of foreign exchange market distortions and a recent expansionary monetary stance has increased pressure on the exchange rate.
Economist John Robertson said the country should increase its exports to generate more foreign currency and have an increased ability to create its own money.
“We need to increase our exports by increasing production in order to earn more foreign currency and reduce our imports. We also need to increase the ability to create our own money so that we will not have to rely more on using foreign currency,” Robertson said.
He added that the prevailing economic environment is not conducive for investors because it kills market confidence.
“We are not getting any investors in the country because this environment is hostile to investors. We have created an economy that is harmful to ourselves. Some people are saying money is losing value, hence they are taking their money and banking it somewhere else which is not in this country, hence we still have cash shortages.”
Last week, the RBZ issued a directive to all banks to freeze the accounts of companies suspected of engaging in money-laundering activities and fuelling the foreign currency parallel market.
Before lifting the prohibition order, the central bank also banned all cash-in, cash-out and cash-back transactions, in a bid to eliminate the buying and selling of cash at a premium.
All these efforts have proven fruitless as the hard cash and foreign currency shortages persist"...................Zimbabwe is a basket case with sky high political & economic risks & the incompetent, low skilled CMCL management team of Steve Curtis, Dana Roets & Mark Learmonth have married CMCL shareholders to Zimbabwe, the most scorned country in the world by most gold stock investors.
Citizens must prepare for Zimbabwe’s economic Armageddon
October 4, 2019 8:25 PM
Source: Citizens must prepare for Zimbabwe’s economic Armageddon – The Zimbabwean
For the past fourteen months, since election 2018, we’ve been paralyzed, helplessly witnessing the government converting our US dollars into useless Zim dollars, watching the loss of our savings, erosion of our incomes, soaring inflation and a new frenzy of looting and corruption. Hunger is knocking on Zimbabwe’s door this October 2019.
Some of it we can blame on last season’s drought but we also have to apportion responsibility to the latest ‘missing billions’ story from Zimbabwe. We don’t do corruption in thousands or hundreds of thousands in Zimbabwe anymore, now it’s always in the millions and billions of disappeared US dollars. Parliament is still waiting for answers as to what happened to US$3 billion allocated for agriculture which can’t be accounted for since the government’s Command Agriculture scheme started in 2016. The missing billions didn’t translate into the grain in our silos so where did it go? Mansions? Luxury cars? Foreign bank accounts? And before we even get the answers to all that missing money or Mr Mugabe’s self-confessed missing US$15 billion or ZINARA’s missing $25 billion, President Mnangagwa just announced an additional injection of ZW$1.8 billion and US$51 million into this year’s Command Agriculture programme. More seed and fertilizer or more mansions and cars?
Last week the US Ambassador to Zimbabwe, Brian Nichols, exposed the one simple fact about our agricultural capability which we all know; a fact which should be cause for national shame twenty years after Zanu PF’s seized all commercial farmland in Zimbabwe. Ambassador Nichols said: “In the 1990s, there was a deep drought in the region and all Southern African nations were fed by Zimbabwe, but now this country requires food aid to feed half of its rural population.”
With just a couple of weeks to go until our main planting season, the stacks of seed maize are piled high in the supermarkets but no one can afford to buy it. This morning in my home town seed maize is selling for ZW$389 for 10 kgs and Compound D fertilizer is ZW$500 for 50 kgs. ZW$900 to plant one acre of maize is more than a lecturer earns in a month, more than a domestic or garden worker earns in five months. Desperate to try and survive the ravages of inflation which international economist Steve Hanke puts at over 800% a year, people are left with no choice but to plant maize pips left from last year’s harvest and just hope for the best. Even more alarming are the current huge empty gaps on supermarket shelves where the staple maize meal usually is; the price sticker is there: ZW$59.89 for 10 kgs but there has been nothing to buy for the past fortnight or more.
With such a massive food disaster in the making and at a time when almost half the population need international food aid, the Zimbabwe government have been diverting our attention with a rash of new financial regulations and Statutory Instruments, just as they did at the height of the last economic crash in 2008. It is now illegal to display, quote, charge, sell, pay for or receipt goods and services in US dollars or any currency other than ZWL dollars. Large fines have been tagged on to the latest rash of financial constraints which look very much like sending us headlong back to the days of empty shelves as the government takes control of every single US dollar out there and businesses are left with nothing to use to import the goods they require.
A fortnight ago the Reserve Bank announced that Bureau de Change could not pay out more than 7% of the bank stipulated rate when buying currency. Two days ago they dropped the rate again to between 3 and 5%. At the beginning of this week the Reserve Bank banned all cash in, cash out and cashback transactions offered by the country’s mobile phone money operator, Ecocash saying they were trying to protect consumers from abuse and profiteering. In a country where banks don’t have any money and 90% of the population don’t have bank accounts, Ecocash has become the lifeblood of Zimbabwe. An uproar ensued and within three days the Reserve Bank backtracked on the ban.
Frankly, it’s a nightmare trying to understand and keep up with all these rules, regulations and iron fist policies and these words from ZCTU President Peter Mutasa offer the best summary of the current situation: “What the RBZ is doing is not new; the same institution blamed everyone but itself in 2007-2008. It went on the same spree and churned out Statutory Instruments weekly… but failed to reverse hyperinflation. … It is wasting time and burying the head in the sand…. These arbitrary policies are going to destroy the few remaining companies and jobs.” Mutasa concluded with the chilling words: “Citizens must prepare for the 2008 financial and economic Armageddon.”
CMCL share price on April 24th 2018 topped out at $9.90. The gold price that day was $1330. Today CMCL closed at $6.98 & the gold price closed at $1522. Gold price up $192, while CMCL share price has DECLINED $2.92 or 29.5% in the same time period. A small part of that decline was due to dividends. This reflects the incompetence of CMCL management & the never ending, sky high Zimbabwe political & economic risk. An increased CMCL dividend would offset these handicaps, send CMCL's share price much higher, possibly to new highs with the expansion fully funded. Enough said.
"HEY MARC....... I AM NOT INTERESTED IN ANY DIVIDEND INCREASE" ... HEY SHERM.... Bottom line is CMCL can increase the dividend & fund the expansion at $1500+ gold. Increasing the dividend will attract new CMCL investors, immediately raise the share price & increase the wealth of the stockholders which is the prime responsibility of management. I AM INTERESTED IN A STOCK THAT INCREASES DIVIDENDS & HAS A RISING SHARE PRICE. YOU ARE NOT. You are probably the only CMCL investor that wouldn't like having more cold hard CMCL cash dividends in their pocket. LOL
Bottom line is at $1500+ gold, CMCL could fund the expansion & increase the dividend. Increasing the dividend now will boost the share price & attract new buyers to offset CMCL incompetent management & the curse of never ending, sky high political & economic risk of doing business in reviled Zimbabwe. Increasing dividends & a rising share price is what I call GROWTH.
"Do you really think that the Company can pay .14 per share in addition to building the expansion of Blanket"......Management previously said it needed a gold price of $1250 to fund the expansion. IF THAT IS CORRECT, the dividend could be doubled as the gold price at $1500/oz is $250/oz higher than the price required to fund the expansion.
There were multiple tops around $6.40. It appears that this resistance has been over come & a new uptrend could be starting. If Curtis doubled the dividend, CMCL would explode to new highs.
Finally some upside volume. A three day close over $6.50 could be signaling the start of a new uptrend in response to the over $300 rise in the price of gold.
Gold up $29 & CMCL DOWN .01. Gold stock investors are still avoiding CMCL like it is the black plague, even though CMCL is a profitable, dividend paying gold company unfortunately located in the most gold stock investor avoided country in the world, Zimbabwe. Zimbabwe is a basket case & has sky high, never ending political & economic risks that gold stock investors want no part of. Gold stock investors know that the CMCL management team of Dana Roets, Mark Learmonth & Steve Curtis is incompetent, low skilled & incredibly greedy. These incompetent bozos voted themselves undeserved bloated salaries & achievement options. Total compensation for each is about $500,000 a year. These greedy low skilled "managers" granted themselves achievement options NOT based on share price performance, stealing this option money directly from shareholders pockets. CMCL needs new aggressive competent, highly skilled management that can guide CMCL to it's full future potential. The one thing these bozos can do to induce gold stock investors to invest in CMCL is to immediately double the dividend to compensate for CMCL incompetent management & Zimbabwe super high political & economic risk.
"Quit blaming the victim. She's a scientist, academic and researcher, not a Wharton MBA. MOst academics are clueless about business.".....What an absurd statement. "Dr. Paterson founded Advaxis, which today has multiple clinical programs built upon her discoveries. Dr. Paterson serves as a consultant to Advaxis"...Paterson discovered the LM technology, FOUNDED ADXS & is a consultant to the company. To post that she is a victim & she is clueless about the company she founded is at best very naïve. Paterson also had all the academics at the University of Pennsylvania's Wharton School of Business to advise her about ADXS management & the functioning of the company. Paterson chose to stay silent & invisible. She deserves to have her LM Technology dream crushed.
"What is she gonna say? I got conned by Sidransky?
NOthing she says will make her shares valuable again."....Patterson could have taken a much more active role in choosing the management & functioning of ADXS but she chose not to. Patterson is getting exactly what she deserves for staying silent & invisable. After devoting many years of her life inventing LM Technology, her dream is crushed & her stock has very little value.
What is really bizarre is the stone cold silence from LM Technology inventor Yvonne Patterson. Her dream & her work has been destroyed, any stock she owns can't be worth very much. However, only dead silence from Patterson.
"People finally saw through the scam. Our Gen 1 products were all duds, and the tests were just wastes of money. So we admitted defeat and our now trying to sell P1 hopes of NEO and preclinical HOT as the future.".... I posted many times that Berlin was nothing but a con man & made it very clear that this was the ADXS con Berlin was attempting to dupe the market & gullible ADXS shareholders with. The market was not duped & promptly collapsed the stock & continues to do so. Those that heeded my posts saved themselves from an ADXS wipe out. Those ADXS shareholders that ignored my warning lost almost every penny they gambled on Berlin & his con game. Ken Berlin is vermin.
From Q2 report. The CMCL dividend is in jeopardy because of the financial risk of doing business in Zimbabwe............................................................14. DIVIDEND POLICY
Caledonia’s current dividend policy is a dividend of 6.875 cents payable at the end of January, April, July and October. As discussed in section 4.9, monetary conditions in Zimbabwe have worsened and there is an increased risk that Caledonia will not be able to effect payments from Zimbabwe which are sufficient to fund further dividend payments......The incompetent, low skilled management team of Dana Roets, Steve Curtis & Mark Learmonth should be replaced by new, aggressive, competent & highly skilled management to guide CMCL to it's full future potential.
ADXS failed LM Technology obsolete & left in the dust by INOVIO.
Inovio Completes Enrollment of its VGX-3100 Open-label Phase 2 Trial for Treatment of HPV-Related High-Grade Anal Dysplasia
PR Newswire PR NewswireAugust 19, 2019
Company to report preliminary efficacy data later this year
PLYMOUTH MEETING, Pa., Aug. 19, 2019 /PRNewswire/ -- Inovio Pharmaceuticals, Inc. (INO) announced today that it has completed enrollment in the company's open-label, 24 patient, Phase 2 trial with its lead immunotherapy product VGX-3100 in patients with precancerous lesions of the anus, i.e. anal high-grade squamous intraepithelial lesions (anal HSIL, aka anal intraepithelial neoplasia). VGX-3100 is an immunotherapy that targets human papillomavirus (HPV) 16 and 18 and is being studied for the treatment of HPV-related precancerous lesions and the HPV infection that causes these lesions. Inovio is already evaluating VGX-3100 in two Phase 3 registration trials to treat cervical dysplasia caused by HPV, for which the company has previously announced the completion of enrollment for the first of those pivotal trials, REVEAL 1.
This open-label, multi-center Phase 2 study is designed to evaluate the safety and efficacy of VGX-3100 administered Inovio's CELLECTRA® delivery system in adult men and women with anal HSIL caused by HPV-16 and/or HPV-18 and builds on significant clinical benefits demonstrated with Inovio's HPV immunotherapies in multiple clinical trials. VGX-3100 in a Phase 2 proof-of-concept trial for cervical dysplasia demonstrated a complete response in 43 out of 107 patients in regression of high grade cervical lesions and elimination of the underlying HPV infection. Additional 2 out of 4 metastatic head and neck cancer patients treated with MEDI0457 and a PD-1 check point inhibitors in a Phase 1 study experienced a long-term complete response for more two years and counting. The other 18 out 22 head and neck patients treated with MEDI0457 have not progressed for over 4 years post-treatment. Lastly, a pilot study of Inovio's immunotherapy in recurrent respiratory papillomatosis (RRP) resulted in 2 out of 2 patients delaying surgery due to lack of tumor recurrence.
Dr. J. Joseph Kim, Inovio's President and CEO, said, "We are very excited to expand the target indication for VGX-3100 to treat rare and difficult to treat diseases like anal HSIL, which have a high recurrence rate that requires multiple, repeat surgeries. A new immunotherapy that could effectively eliminate or delay surgery could be transformative for patients with this high unmet medical condition, Inovio plans to report preliminary efficacy and safety data from this Phase 2 study in the fourth quarter."
Anal HSIL or dysplasia is an orphan disease and the precursor to anal cancer, which is estimated to cause more than 1,280 deaths in the United States in 2019. Anal HSIL is estimated to occur in nearly 20,000 new cases annually. However, that is very likely an underestimate given that no validated screening test exists for the condition and no national registry or reporting exists. Currently, the only treatments for anal dysplasia consist of surgical excision, electro-cautery or laser therapy, but up to 50% of those treated with these current treatments experience recurrence of the disease within one year of treatment and up to nearly 70% within three years of treatment. Therefore, many patients with this condition need multiple treatments. Anal HSIL can lead to HPV-associated squamous cell carcinoma of the anus (SCCA).
Anal cancer is uncommon in the general population, but its incidence is considerably increasing – 64% higher since 1992 -- and is higher among women than in men overall and higher in HIV-positive men and women than in HIV-negative persons. The risk of SCCA among HIV-positive men has continued to increase even after the introduction of highly active antiretroviral therapy. Anal cancer is estimated to have 8,300 new cases diagnosed in the United States in 2019.
About VGX-3100
VGX-3100 is a DNA-based immunotherapy under Phase 3 investigation for the treatment of HPV-16 and HPV-18 infection and precancerous lesions of the cervix. Inovio is in open-label Phase 2 clinical trials evaluating its efficacy for treating HPV-related vulvar and anal precancers. VGX-3100 has the potential to be the first approved treatment for HPV infection of the cervix and the first non-surgical treatment for precancerous cervical lesions. VGX-3100 works by stimulating a specific immune response to HPV-16 and HPV-18, which targets the infection and causes destruction of precancerous cells. In a randomized, double-blind, placebo-controlled phase 2b study in 167 adult women with histologically documented HPV-16/18 cervical HSIL (CIN2/3), treatment with VGX-3100 resulted in a statistically significantly greater regression of cervical HSIL and clearance of HPV-16/18 infection vs. placebo. The most common side effect was injection site pain, and no serious adverse events were reported. VGX-3100 utilizes the patient's own immune system to clear HPV-16 and HPV-18 infection and precancerous lesions without the increased risks associated with surgery, such as loss of reproductive health and negative psychosocial impacts.
From CMCL MD&A August 13, 2019 clearly illustrating one of the extreme political & economic risks of doing business exclusively in Zimbabwe: "Zimbabwe has a severe shortage of foreign exchange which hampers Blanket’s ability to procure the consumables and services it needs to sustain its current operations, to implement the investment programme and to remit funds from Zimbabwe that are needed to sustain Caledonia’s international operations and fund Caledonia’s dividend. Zimbabwe’s rate of inflation has also increased, which has an indirect effect on Blanket’s operations due to the adverse effect on workers morale.".....This reflects the irresponsible, incompetence of CMCL's bozo management team of Steve Curtis, Dana Roets & Mark learmonth policy of being a one trick pony married to Zimbabwe. CMCL shareholders are paying a big time price for the incompetence of these management bozos. No mystery why CMCL's stock is constantly getting hammered & why gold stock investors are treating CMCL stock like it was the black plague. CMCL needs new competent, highly skilled, aggressive management to replace the current management clowns & fulfill CMCL's future potential.
A very poor Q2 report from CMCL. These are the two most important facts after bozo CEO Steve Curtis attempted to put lipstick on this pig. 1-"production guidance for 2019 has been reduced from a range of 53,000 to 56,000 ounces to a range of 50,000 to 53,000 ounces." 2- "Adjusted earnings per share, which excludes unrealised foreign exchange gains, was US$0.268, 19.5% lower than in the second quarter of 2018". The market quickly moved CMCL's share price down again on increased volume clearly voting thumbs down on the incompetent, bumbling CMCL management team. What was glaringly absent from Curtis was any discussion of the the fact that CMCL's share has DECLINED over the past year while the gold price has increased $325 over the past year. Curtis also failed to double the dividend to offset CMCL's incompetent management & Zimbabwe's never ending big time political & economic risk. Very disappointing for all CMCL shareholders who believed in the low skilled, incompetent management team of Steve Curtis, Dana Roets & Mark Learmonth.
$1500 gold & gold stock investors are still avoiding CMCL like it was the black plague even though CMCL is a profitable, dividend paying gold stock. Any increased volume still comes when the stock declines. How can this be? The answer is two fold. CMCL management, Steve Curtis, Dana Roets & Mark Learmonth are incompetent, low skilled & made the ultimate irresponsible decision to stay married to Zimbabwe, a country that is reviled by gold stock investors. Zimbabwe is a basket case economically & has never ending super high political risk even after Mugabe was finally removed from power. CMCL management had the opportunity to diversify CMCL's income & reduce political risk by merging or joint venturing with economic gold properties in mining friendly, very low political risk countries when the gold price collapsed & many of these types of gold companies were under severe financial distress. However, CMCL's bozo management team lacked the skills to find, negotiate & close these types of deals. Instead these clowns made the decision to stay married to Zimbabwe & CMCL's shareholders are paying a very disappointing & big time price for CMCL's management incompetence. The gold price has increased $284 in the last year while CMCL's share price has unbelievably DECLINED from $8 to $6.03, a loss of 25%. At the same time, these greedy incompetent clowns have voted themselves undeserved, bloated salaries & award themselves achievement option NOT based on share price performance, which amounts to stealing from CMCL shareholders. In order to lure gold stock investors to buy CMCL stock, CMCL's dividend should be immediately doubled to offset CMCL's management incompetence & the sky high, never ending political & economic risk in Zimbabwe.
Proof of the total incompetence & failures of CMCL management consider this. In the past one year the gold price has increased $265 or 22% while CMCL's share price has DECREASED $3.11 or 34% in the past one year period. A very small amount of the decline is due to dividends. Why did the CMCL's share price decline 34% while the gold price increased 22%? The obvious answer is the failure of CMCL management, Steve Curtis, Dana Roets & Mark Learmonth to fulfill their number one management responsibility which is to increase the wealth of the shareholders, not the wealth of management. At the same time, these greedy incompetents have voted themselves undeserved obscenely bloated salaries. In addition, these clowns have given all CMCL shareholders a big time slap in the face by rewarding themselves achievement options NOT based on CMCL share price performance. This amounts to stealing from CMCL shareholder capital. To make up for this management failure, the dividend should immediately be doubled considering the $265 increase in the gold price in the past year & any management achievement options should be based on CMCL share price performance only.
Gold up over $30 today. CMCL DOWN slightly, clearly not responding to the higher gold price. Gold stock investors are avoiding CMCL reflecting the extreme political risk of being a one trick pony gold company operating exclusively in Zimbabwe & the incompetence & low skills of CEO Steve Curtis & the rest of CMCL's bozo management team.
CMCL's management has voted themselves undeserved bloated salaries. For the year 2018 CEO Steve Curtis salary was $450,000. Total compensation $575,562 salary plus options. Dana Roets, chief operating officer- salary-$418,182. Total compensation salary plus options-$512,678. Mark Learmonth CFO - salary $410,000. Total compensation, salary plus options-$493,267. Adam Chester, general council- salary-$359,178. Total compensation, salary plus options-$406,882. This total compensation is obscene, bloated & undeserved. These greedy clowns also have the nerve to grant themselves achievement options in addition to their bloated salaries. These options are NOT based on share price performance because these bozos don't have the testicular fortitude to base their achievement options on share price performance. No management team should ever be granted achievement options that are not based on share price performance because that is NOT in the BEST INTEREST of the SHAREHOLDERS. Basing achievement option on share price performance is in the best interest of the shareholders. It is obvious that CMCL management does what is in their own best interest, not what is best for the shareholders. The number one responsibility of management is to INCREASE the wealth of the shareholders, not management.
"I’m now starting to have some concerns for the first time."...If you read my many posts, you would have clearly seen that con man Ken Berlin would destroy ADXS shareholder value & that ADXS LM Technology is a failed technology.
Congratulations to Ken Berlin. Berlin is now the overwhelming favorite to win the CEO OF THE YEAR award for the incredible accomplishment he has achieved for ADXS shareholders. This achievement is a whopping 97% COLLAPSE of the ADXS share price since the day Berlin was anointed ADXS CEO. This clearly illustrates Berlin's superior management skills, expertise, competence & his clear plan for ADXS shareholders. Bravo Ken Berlin!
"We all screwed up! Plain and simple! These guys have it all figured out in regards to their exit strategy.".....Not everyone screwed up. I posted many times that ADXS CEO Ken Berlin was a con man that would destroy ADXS & I was 100% correct. Those that were wise enough to follow my advise, escaped the carnage. Those that didn't & were duped by Berlin's con game did screw up & paid the price. Con man Ken Berlin is vermin.
The main reason CMCL stock has so far miserably failed to increase in price while the gold price has exploded is because of the incompetent, low skilled CMCL management. CEO Steve Curtis committed the cardinal sin of staying married to Zimbabwe & the extreme, never ending, sky high political risk of doing business in Zimbabwe. Even after Mugabe was removed, Zimbabwe is still an economic & political basket case with big time political risk that gold stock investors are avoiding like the black plague even though CMCL is a profitable, dividend paying gold company. Curtis had the chance, when the gold price collapsed & many quality gold properties were on the verge of extinction, to diversify CMCL's income & greatly reduce CMCL's political risk by either merging or joint venturing with financially distressed, economic, producing or near producing gold properties in mining friendly, very low political risk countries. However, Curtis & the rest of CMCL's incompetent management team lack the skills necessary to identify, negotiate & close deals to diversify CMCL's income & greatly reduce the never ending extreme political risk of doing business in Zimbabwe. If it were not for the dividend, which was established before Curtis was appointed CEO, CMCL's stock price would be trading for probably half of the current stock price. A very ugly & disappointing picture for CMCL shareholders, while CMCL's bozo management team pays itself bloated, undeserved salaries & options.
"I really think the Undertaker may have gotten taken.".... Ken Berlin was NOT taken. Berlin knew when he was anointed CEO that AXAL was a dud, would never get FDA or EU approval & would never get to market. That is why Berlin attempted to con, defraud & dupe the market & all ADXS shareholders with his pathetic con game. Most all ADXS shareholders fell for the con hook, line & sinker & Berlin purposely murdered the warrant holders. The market however was not duped by Berlin & collapsed the ADXS stock price a whopping 94% since the day grifter Berlin was anointed ADXS CEO. Berlin is vermin.
Ever since con man Ken Berlin was anointed ADXS CEO, the ADXS share price has collapsed an incredible, whopping 93% in value. I posted many times that this decline was inevitable. This is an amazing accomplishment that only Berlin could achieve while getting paid a undeserved, bloated salary by the shareholders & warrant holders he purposely mirdered. Ken Berlin is vermin.
"It is a fact that no BP has partnered on AXAL cervical."... That's 100% correct. After over 7 years & in a phase3 FDA trial that con man Ken Berlin has stopped, after multi million dollars of shareholder capital was squandered on AXAL, BP wants no part of AXAL, NEO, which Amgen dumped, or HOT. Collapsed share price & money talks, while BS nonsnense walks.
Once again the failed. obsolete, AXAL left in the dust again. ..............................................................................................................................Inovio completes enrollment in late-stage of VGX-3100 in HPV;
•Inovio Pharmaceuticals (NASDAQ:INO) has completed target enrollment of 198 participants for its Phase 3 registration trial ("REVEAL 1") of VGX-3100, a DNA-based immunotherapy being tested to treat cervical dysplasia caused by human papillomavirus (HPV).
•A confirmatory Phase 3 trial (REVEAL 2) is currently enrolling with FDA submission expected in 2021.
•The primary endpoint of the Phase 3 study is regression of cervical HSIL and virologic clearance of HPV 16 and/or HPV 18 in the cervix.
•The studies will evaluate cervical tissue changes at approx. 9 months after beginning a three dose regimen administered at months 0, 1, and 3.
"It wouldn’t be the first construct to be shown to be effective without a BP partnership and it wouldn’t be the last either." ....Bottom line still the same. Collapsed share price & money talks, while BS nonsense walks.
Bottom line is that zero BP offered to partner with or buy out ADXS, which BP could do for less than peanuts, for AXAL, NEO, HOT or any ADXS product based on the failed ADXS LM Technology. Money & the collapsed share price talks while BS nonsense walks.
"There is obviously some business reason that no BP has bitten yet."....The business reason zero BP don't want any part of AXAL, NEO, dumped by Amgen, Hot, ADXS LM Technology, or ADXS the company is that every BP has concluded that AIM2Cerv (AXAL) doesn’t work.
" The claim that it is being dropped because it is a “failed technology” is moronic."....That is a totally ignorant statement. If AXAL was not a failed technology, take it to the bank that BP, who could have total ownership of AXAL for less than peanuts, would have bought out ADXS & "steal" AXAL. The proof that the statement is so obviously ignorant & moronic is the stone cold fact that ZERO BP want any part of AXAL, NEO, which was dumped by Amgen, HOT, ADXS LM Technology or ADXS the company.
"Nobody is touching the science...don't think that's Berlin."... As I posted many times, ADXS LM Technology is a failed technology. Vermin Berlin was well aware when he was anointed ADXS CEO that the LM technology was a bust. That is why nobody is touching the science.
Now that Berlin has buried AXAL, every ADXS shareholders knows that what I posted many times on the board was 100% correct. Ken Berlin is nothing but a third rate con man, grifter, swindler, that duped, raped & pillaged all naïve & gullible ADXS shareholders & caused them to lose all, or almost all, of the money they gambled away on ADXS stock & warrants. ADXS stock has lost an unbelievable, whopping 90% of it's value since Berlin was anointed ADXS CEO. The market was not duped by the obvious Berlin con game. Berlin also murdered all ADXS warrant holders as he purposely let the warrants expire worthless. Berlin is vermin.
"His call to shelve AXAL was crazy. Why would a CEO state that on a CC then backtrack a few months later with some crazy FDA timeline adjustment...unless there was a partner asking for it."... As I posted many times, no BP that wants to partner with ADXS because they know the ADXS "LM technology platform" is a dud, probably obsolete & will never get to market.
"NEO was billed ADXS' next gen (i.e. last hope). That all changed when Amgen saw the initial data and bailed."... As I posted many times, this was a big part of Ken Berlin's con in his attempt to dupe the market & scam ADXS shareholders. Con man Ken Berlin knew that AXAL was a dud when he was anointed ADXS CEO so he had to change the ADXS narrative. He threw AXAL under the bus & proclaimed that NEO & HOT were the next big ADXS "LM technology platform" vaccines that could cure various forms of cancer. The market didn't fall for Berlin's con game & collapsed ADXS stock from a split adjusted $24.25 to $2.95 today, a whopping decline of 88% since Berlin was anointed ADXS CEO. Con man Ken Berlin duped most ADXS shareholders & caused then monster losses of the money they gambled on ADXS stock & ADXS warrants. Con man Ken Berlin is vermin.